Triple-negative breast cancer (TNBC), which does not express ER, PR, and HER2, exhibits aggressive tumorigenicity and results in high mortality due to a lack of therapeutic targets compared to other subtypes [11]. The gene discussed is PGR; the disease is triple-negative breast carcinoma.